Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/XLIFE-SCIENCES-AG-133157244/news/VERAXA-Biotech-AG-acquires-Synimmune-GmbH-to-expand-cancer-pipeline-45650800/?utm_source=whatsapp&utm_medium=social&utm_campaign=share